| Description |
-
Background: Systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is one of the leading causes of death in SSc. Identification of a serum-based proteomic diagnostic biomarker for SSc-PAH would allow for rapid non-invasive screening and could positively impact patient survival. Identification and validation of novel proteins could potentially facilitate the identification of SSc-PAH, ... read moreand might also point to important protein mediators in pathogenesis.
Keywords: Classification, Proteomic, Scleroderma, Biomarkers, Pulmonary arterial hypertension.
Springer Open.read less
|
|---|
This object is in collection
